KAMPALA - Uganda’s Cabinet has approved the appointment of the board of directors of the National Drug and Health Products Authority (NDHPA).
The Authority is established as a body corporate under the NDHPA Act, 2026, and being a body corporate means it has its own legal identity; it can own property, enter into contracts, and sue or be sued in its own name.
Its seven members include Dr. Christine Kininga Tashobya (chairperson), Dr. Jerome Mpaata Owagage, Eng. Tadeo Byabagambi, Margaret Nalwoga, Catherine Adok, Dr. Francis Omujal, and Gaddafi Nassur.
Tashobya has a PhD in public health and three master’s degrees in public health, health policy planning and financing, and demography.
She also has a Bachelor of Medicine and Bachelor of Surgery and 35 years’ experience in public health and health systems governance, according to information provided by ICT and National Guidance Minister Justine Kasule Lumumba.
The minister shared the approved NDHPA board members and their areas of expertise during a press conference at the Uganda Media Centre in Kampala on Tuesday (November 10), while communicating decisions made during Monday’s Cabinet meeting at State House, Entebbe.
The Cabinet decisions included the approval of NDHPA board of directors. “The Authority’s board members will serve for four years and are eligible for reappointment for one additional term,” Lumumba said.
Dr. Owagage, a health law expert, is from the Pharmaceutical Society of Uganda, while Eng. Byabagambi is an expert in biomedical engineering and medical devices.
Nalwoga is an expert in financial management and forensic investigations, Dr. Omujal is a lawyer and human rights advocate, and Gaddafi is a farmer and former national chairman of the National Resistance Movement party youth league.
Lumumba said Gaddafi has a degree in Natural Chemotherapeutics and Traditional Medicine.
President Yoweri Museveni assented to the new NDHPA Act on April 27, 2026, which repealed the National Drug Policy and Authority Act of 1993 and broadened regulatory oversight to cover pharmaceuticals, medical equipment, diagnostics, public health chemicals and cosmetics.